Current Applications of Nanoemulsions in Cancer Therapeutics
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly water soluble due to their hydrophobic core nature. Additionally, they are also composed of safe gradient excipients, which makes them a stable and safe option to deliver drugs. Cancer therapy has been an issue for several decades. Drugs developed to treat this disease are not always successful or end up failing, mainly due to low solubility, multidrug resistance (MDR), and unspecific toxicity. Nanoemulsions might be the solution to achieve efficient and safe tumor treatment. These formulations not only solve water-solubility problems but also provide specific targeting to cancer cells and might even be designed to overcome MDR. Nanoemulsions can be modified using ligands of different natures to target components present in tumor cells surface or to escape MDR mechanisms. Multifunctional nanoemulsions are being studied by a wide variety of researchers in different research areas mainly for the treatment of different types of cancer. All of these studies demonstrate that nanoemulsions are efficiently taken by the tumoral cells, reduce tumor growth, eliminate toxicity to healthy cells, and decrease migration of cancer cells to other organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 2×
“The encapsulation protects the drug from degradation and increases its half-life in the plasma [4].”
BackgroundMethodNormalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 2×
“Active targeting moieties connect to over-expressed receptors in cancer cells like folate [18], transferrin [19], epidermal growth factor (EFGR) [20], or prostate-specific membrane antigen (PSMA) [21].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 1×
“Texture modifiers, weighting agents or ripening retarders can also be used [47,48].”
BackgroundAnalysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643 · cited 1×
“The main problem in the metabolism of nanoemulsions is the hepatic clearance [72].”
BackgroundKeefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149 · cited 1×
“Conjugation with polyethylene glycol (PEG) [38], cationic liposomes [39], micelle polyelectrolyte complex (PEC) [40], lipidic and plasmidic DNA complexes [41], and pH-sensitive nanocarriers [42] may help with the remaining problems, enhancing the success of cancer therapy.”
BackgroundNanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2012) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,778
Cunningham, D., Atkin, W., Lenz, H.-J., Lynch, H. T., Minsky, B., Nordlinger, B., & Starling, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60353-4 · Cited by 1,351
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Edible nanoemulsions: fabrication, properties, and functional performance
McClements, D. J. (2011) · Soft Matter · doi:10.1039/c0sm00549e · Cited by 1,031
Nanoemulsions: formation, structure, and physical properties
Mason, T. G., Wilking, J. N., Meleson, K., Chang, C. B., & Graves, S. M. (2006) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/18/41/r01 · Cited by 998
Qian, C., & McClements, D. J. (2011) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2010.09.017 · Cited by 908
Cancer cells compress intratumour vessels
Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K. (2004) · Nature · doi:10.1038/427695a · Cited by 857
Impact of Oil Type on Nanoemulsion Formation and Ostwald Ripening Stability
Wooster, T. J., Golding, M., & Sanguansri, P. (2008) · Langmuir · doi:10.1021/la801685v · Cited by 846
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Minimum information reporting in bio–nano experimental literature
Faria, M., Björnmalm, M., Thurecht, K. J., Kent, S. J., Parton, R. G., Kavallaris, M., Johnston, A. P. R., Gooding, J. J., Corrie, S. R., Boyd, B. J., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0246-4 · Cited by 710
Soenen, S. J., Rivera-Gil, P., Montenegro, J.-M., Parak, W. J., De Smedt, S. C., & Braeckmans, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.001 · Cited by 699
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Hu, C.-M. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 686
Elnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649
Nanoemulsions: formation, structure, and physical properties
Mason, T. G., Wilking, J. N., Meleson, K., Chang, C. B., & Graves, S. M. (2007) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/19/7/079001 · Cited by 626
Emulsion Design to Improve the Delivery of Functional Lipophilic Components
McClements, D. J. (2010) · Annual Review of Food Science and Technology · doi:10.1146/annurev.food.080708.100722 · Cited by 541
Yuan, Y., Gao, Y., Zhao, J., & Mao, L. (2008) · Food Research International · doi:10.1016/j.foodres.2007.09.006 · Cited by 505
Ganta, S., & Amiji, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 490
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Gillet, J.-P., Calcagno, A. M., Varma, S., Marino, M., Green, L. J., Vora, M. I., Patel, C., Orina, J. N., Eliseeva, T. A., Singal, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111840108 · Cited by 477 · cited 1×
“Combination of DHA with paclitaxel resulted in a weak decrease in P-gp and ABC transporters [99].”
BackgroundABC Transporters, Drug Resistance, and Cancer Stem Cells
Dean, M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9109-9 · Cited by 425
Current State of Nanoemulsions in Drug Delivery
Lovelyn, C., & Attama, A. A. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225075 · Cited by 411
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Antibody‐Conjugated Nanoparticles for Biomedical Applications
Arruebo, M., Valladares, M., & González-Fernández, Á. (2009) · Journal of Nanomaterials · doi:10.1155/2009/439389 · Cited by 331
Klang, V., Matsko, N. B., Valenta, C., & Hofer, F. (2012) · Micron · doi:10.1016/j.micron.2011.07.014 · Cited by 329
Optimization of nano-emulsions production by microfluidization
Jafari, S. M., He, Y., & Bhandari, B. (2007) · European Food Research and Technology · doi:10.1007/s00217-006-0476-9 · Cited by 326
Macrophage Uptake of Core−Shell Nanoparticles Surface Modified with Poly(ethylene glycol)
Zahr, A. S., Davis, C. A., & Pishko, M. V. (2006) · Langmuir · doi:10.1021/la060951b · Cited by 324
Risk of Colorectal Cancer in the Families of Patients with Adenomatous Polyps
Winawer, S. J., Zauber, A. G., Gerdes, H., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Bond, J. H., Waye, J. D., Schapiro, M., Panish, J. F., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340204 · Cited by 323
Modi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 307
Folate receptor-targeted drugs for cancer and inflammatory diseases
Low, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.003 · Cited by 306
Leu, J.-G., Chen, S.-A., Chen, H.-M., Wu, W.-M., Hung, C.-F., Yao, Y.-D., Tu, C.-S., & Liang, Y.-J. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.013 · Cited by 284
Lu, W., Zhang, G., Zhang, R., Flores, L. G., Huang, Q., Gelovani, J. G., & Li, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3379 · Cited by 266
Drug delivery and drug targeting with parenteral lipid nanoemulsions — A review
Hörmann, K., & Zimmer, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.016 · Cited by 264
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.021 · Cited by 260
Docetaxel and Paclitaxel in the Treatment of Breast Cancer: A Review of Clinical Experience
Crown, J., O'Leary, M., & Ooi, W.-S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_2-24 · Cited by 249
Advantages of liposomal delivery systems for anthracyclines
Allen, T. M., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.001 · Cited by 248
Nanoemulsions in Translational Research—Opportunities and Challenges in Targeted Cancer Therapy
Ganta, S., Talekar, M., Singh, A., Coleman, T. P., & Amiji, M. M. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0088-9 · Cited by 240
Wang, C. Y., & Huang, L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7851 · Cited by 239
Periasamy, V. S., Athinarayanan, J., & Alshatwi, A. A. (2016) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2016.01.035 · Cited by 235
Drug targeting and tumor heterogeneity
Bae, Y. H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.074 · Cited by 233
Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K., Mukhtar, H., & Gong, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.006 · Cited by 223
Mohammad, I. S., He, W., & Yin, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.038 · Cited by 218
“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes
Fattal, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.037 · Cited by 211
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
Zhang, C., Tang, N., Liu, X., Liang, W., Xu, W., & Torchilin, V. P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.022 · Cited by 210
Nanoparticles for Drug Delivery
(2021) · Gels Horizons: From Science to Smart Materials · doi:10.1007/978-981-16-2119-2 · Cited by 203
A primer on the mechanics of P-glycoprotein the multidrug transporter
Hennessy, M., & Spiers, J. P. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.10.007 · Cited by 199
Mein, J. R., Lian, F., & Wang, X.-D. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00120.x · Cited by 191
Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications
Jiao, M., Zhang, P., Meng, J., Li, Y., Liu, C., Luo, X., & Gao, M. (2018) · Biomaterials Science · doi:10.1039/c7bm01020f · Cited by 185
Milane, L., Duan, Z., & Amiji, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161
Clares, B., Calpena, A. C., Parra, A., Abrego, G., Alvarado, H. L., Fangueiro, J. F., & Souto, E. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.001 · Cited by 160
Self-citationFormation and stability of nano-emulsions
TADROS, T. (2004) · Advances in Colloid and Interface Science · doi:10.1016/s0001-8686(03)00157-x · Cited by 159
Stolnik, S., Daudali, B., Ariën, A., Whetstone, J., Heald, C. R., Garnett, M. C., Davis, S. S., & Illum, L. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00376-5 · Cited by 146
Monge‐Fuentes, V., Muehlmann, L. A., Longo, J. P. F., Silva, D., Fascineli, M. L., Souza, P. D., Faria, F., Degterev, I. A., Rodriguez, A. F. R., Carneiro, F. P., et al. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.12.002 · Cited by 143
Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
Neubi, G. M. N., Opoku‐Damoah, Y., Gu, X., Han, Y., Zhou, J., & Ding, Y. (2018) · Biomaterials Science · doi:10.1039/c8bm00175h · Cited by 126
Critical steps and energetics involved in a successful development of a stable nanoemulsion
Qadir, A., Faiyazuddin, M., Hussain, T., Alshammari, T. M., & Shakeel, F. (2015) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.11.050 · Cited by 124
Meng, L., Xia, X., Yang, Y., Ye, J., Dong, W., Ma, P., Jin, Y., & Liu, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.001 · Cited by 114
A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers
Ganta, S., Deshpande, D., Korde, A., & Amiji, M. M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.497971 · Cited by 109
Impact of Weighting Agents and Sucrose on Gravitational Separation of Beverage Emulsions
Chanamai, R., & McClements, D. J. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0002903 · Cited by 108
Ma, Y., Liu, D., Wang, D., Wang, Y., Fu, Q., Fallon, J. K., Yang, X., He, Z., & Liu, F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400778r · Cited by 100
Poloxamine-based nanomaterials for drug delivery
Alvarez‐Lorenzo, C. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e102 · Cited by 99
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA
Toub, N., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.093 · Cited by 96
Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin
Li, H., Krstin, S., & Wink, M. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.169 · Cited by 89
Structure and Structure—Function Studies of Lipid/Plasmid DNA Complexes
Lin, A. J., Slack, N. L., Ahmad, A. K., Koltover, I., George, C., Samuel, C. E., & Safinta, C. (2000) · Journal of drug targeting · doi:10.3109/10611860009009206 · Cited by 88
Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging
Fernandes, D. A., Fernandes, D. D., Li, Y., Wang, Y., Zhang, Z., Rousseau, D., Gradinaru, C. C., & Kolios, M. C. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b01867 · Cited by 88
Cremophor EL, solvent for paclitaxel, and toxicity
Liebmann, J., Cook, J., & Mitchell, J. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92789-v · Cited by 85
Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene
Chen, B., Huang, R.-F. S., Wei, Y., & Inbaraj, B. S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79107 · Cited by 84
Botchkina, G. I., Zuniga, E. S., Das, M., Wang, Y., Wang, H., Zhu, S., Savitt, A. G., Rowehl, R. A., Leyfman, Y., Ju, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-192 · Cited by 80
Yu, H., Xu, Z., Chen, X., Xu, L., Yin, Q., Zhang, Z., & Li, Y. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300282 · Cited by 72
Lefebvre, G., Riou, J., Bastiat, G., Roger, E., Frombach, K., Gimel, J.-C., Saulnier, P., & Calvignac, B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.017 · Cited by 72
Migotto, A., Dartora, V. F. C., Salata, G. C., da Silva, F. W. M., Yan, C. Y. I., Ishida, K., Costa-Lotufo, L. V., Steiner, A. A., & Lopes, L. B. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1440665 · Cited by 72
Jones, R. J., Hawkins, R. E., Eatock, M. M., Ferry, D. R., Eskens, F. A. L. M., Wilke, H., & Evans, T. R. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0486-8 · Cited by 71
Vitamin E reverses multidrug resistance in vitro and in vivo
Tang, J., Fu, Q., Wang, Y., Racette, K., Wang, D., & Liu, F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.020 · Cited by 71
Caron, W. P., Lay, J. C., Fong, A. M., La-Beck, N. M., Kumar, P., Newman, S. E., Zhou, H., Monaco, J. H., Clarke‐Pearson, D. L., Brewster, W. R., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208801 · Cited by 71
Ahmad, G., Sadda, R. R. E., Botchkina, G. I., Ojima, I., Egan, J., & Amiji, M. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.004 · Cited by 67
Chen, B., & Chang, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87225 · Cited by 64
Tiwari, S. B., Tan, Y.-M., & Amiji, M. M. (2006) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2006.038 · Cited by 63
Natesan, S., Sugumaran, A., Ponnusamy, C., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.05.127 · Cited by 61
Nanoemulsion Based Targeting in Cancer Therapeutics
Kumar, G. P. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000275 · Cited by 60
Journo-Gershfeld, G., Kapp, D., Shamay, Y., Kopeček, J., & David, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0672-1 · Cited by 59
Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer
Verma, P., Meher, J. G., Asthana, S., Pawar, V. K., Chaurasia, M., & Chourasia, M. K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.920430 · Cited by 59
Hsu, H., Huang, R.-F. S., Kao, T.-H., Inbaraj, B. S., & Chen, B. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa5e86 · Cited by 59
The role of cancer stem cells in tumor heterogeneity and resistance to therapy
Konrad, C. V., Murali, R., Varghese, B. A., & Nair, R. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0079 · Cited by 56
Chrastina, A., Baron, V. T., Abedinpour, P., Rondeau, G., Welsh, J., & Borgström, P. (2018) · BioMed Research International · doi:10.1155/2018/9035452 · Cited by 56
Najlah, M., Kadam, A. N., Wan, K., Ahmed, W., Taylor, K. M. G., & Elhissi, A. M. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.027 · Cited by 55
Recent Trends in Clinical Trials Related to Carrier-Based Drugs
Tagami, T., & Ozeki, T. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.02.026 · Cited by 54
Al-Abd, A. M., Hyeon, L. S., Kim, S. H., Cha, J., Park, T. G., Lee, S. J., & Kuh, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.009 · Cited by 52
Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian Cancer
Ganta, S., Singh, A., Patel, N. R., Cacaccio, J., Rawal, Y. H., Davis, B. J., Amiji, M. M., & Coleman, T. P. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1345-z · Cited by 50
Talekar, M., Ganta, S., Singh, A., Amiji, M. M., Kendall, J. D., Denny, W. A., & Garg, S. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0793-6 · Cited by 49
Chen, G., Wang, K., Wu, P., Wang, Y., Zhou, Z., Yin, L., Sun, M., & Oupický, D. (2017) · Nano Research · doi:10.1007/s12274-017-1946-z · Cited by 49
Qi, K., Al-Haideri, M. T., Seo, T., Carpentier, Y. A., & Deckelbaum, R. J. (2003) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710302700158 · Cited by 47
Zhao, C., Feng, Q., Dou, Z., Yuan, W., Sui, C., Zhang, X., Xia, G., Sun, H., & Ma, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073860 · Cited by 43
Development of lycopene micelle and lycopene chylomicron and a comparison of bioavailability
Chen, Y. J., Inbaraj, B. S., Pu, Y., & Chen, B. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/15/155102 · Cited by 42
Kim, B., Pena, C. D., & Auguste, D. T. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01065 · Cited by 42
Kim, J.-E., & Park, Y. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.261 · Cited by 41
Luan, L., Chi, Z., & Liu, C. (2019) · Nanomaterials · doi:10.3390/nano9050763 · Cited by 40
Cappellani, M. R., Perinelli, D. R., Pescosolido, L., Schoubben, A., Cespi, M., Cossi, R., & Blasi, P. (2018) · Applied Nanoscience · doi:10.1007/s13204-018-0829-2 · Cited by 35
Servitja, S., Martos, T., Rodríguez-Sanz, M., García‐Giralt, N., Prieto‐Alhambra, D., Garrigós, L., Nogués, X., & Tusquets, I. (2015) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015598536 · Cited by 34
Nanoparticles for Drug Delivery
Tariq, A., Bhawani, S. A., & Moheman, A. (2019) · Advanced structured materials · doi:10.1007/978-981-13-9833-9_9 · Cited by 34
Winter, E., Pizzol, C. D., Locatelli, C., Silva, A. H., Conte, A., Chiaradia-Delatorre, L. D., Nunes, R. J., Yunes, R. A., & Creckzynski-Pasa, T. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111010016 · Cited by 29
Wehrung, D., Geldenhuys, W. J., & Oyewumi, M. O. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.02.005 · Cited by 27
Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding
Matsubara, Y., Katoh, S., Taniguchi, H., Oka, M., Kadota, J., & KOHNO, S. (2000) · Journal of International Medical Research · doi:10.1177/147323000002800203 · Cited by 26
Maranhão, R. C., de Almeida, C. P., Vital, C. G., Contente, T. C., & Maria, D. A. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12293 · Cited by 24
Fávero, G. M., Paz, J. L., Otake, A. H., Maria, D. A., Caldini, E. T. E. G., de Medeiros, R. S. S., Deus, D. F., Chammas, R. J., Maranhão, R. C., & Bydlowski, S. P. (2018) · Oncotarget · doi:10.18632/oncotarget.24389 · Cited by 23
Jiang, G., Tang, S., Chen, X., & Ding, F. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2453-8 · Cited by 17
Cited by
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, W., Arnold, R. D., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010385 · Cited by 581
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.011 · Cited by 267
Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., & Santini, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020146 · Cited by 144
Self-citation
Metadata
- Authors
- Sánchez-López, E., Guerra, M., Dias-Ferreira, J., Lopez-Machado, A., Ettcheto, M., Cano, A., Espina, M., Camins, A., Garcia, M. L., & Souto, E. B.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2019-05-31
- Volume
- 9
- Issue
- 6
- Pages
- 821
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W2947965070
- Cited by
- 276
- References
- 121
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.